677 related articles for article (PubMed ID: 32814791)
1. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
Islam MR; Hoque MN; Rahman MS; Alam ASMRU; Akther M; Puspo JA; Akter S; Sultana M; Crandall KA; Hossain MA
Sci Rep; 2020 Aug; 10(1):14004. PubMed ID: 32814791
[TBL] [Abstract][Full Text] [Related]
2. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
[TBL] [Abstract][Full Text] [Related]
3. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
Uddin MB; Hasan M; Harun-Al-Rashid A; Ahsan MI; Imran MAS; Ahmed SSU
Infect Genet Evol; 2020 Oct; 84():104440. PubMed ID: 32622082
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide.
Isabel S; Graña-Miraglia L; Gutierrez JM; Bundalovic-Torma C; Groves HE; Isabel MR; Eshaghi A; Patel SN; Gubbay JB; Poutanen T; Guttman DS; Poutanen SM
Sci Rep; 2020 Aug; 10(1):14031. PubMed ID: 32820179
[TBL] [Abstract][Full Text] [Related]
5. Time-lapse sentinel surveillance of SARS-CoV-2 spread in India.
Thakur M; Singh A; Joshi BD; Ghosh A; Singh SK; Singh N; Sharma LK; Chandra K
PLoS One; 2020; 15(10):e0241172. PubMed ID: 33091066
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
7. Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.
Long SW; Olsen RJ; Christensen PA; Bernard DW; Davis JJ; Shukla M; Nguyen M; Saavedra MO; Yerramilli P; Pruitt L; Subedi S; Kuo HC; Hendrickson H; Eskandari G; Nguyen HAT; Long JH; Kumaraswami M; Goike J; Boutz D; Gollihar J; McLellan JS; Chou CW; Javanmardi K; Finkelstein IJ; Musser JM
mBio; 2020 Oct; 11(6):. PubMed ID: 33127862
[TBL] [Abstract][Full Text] [Related]
8. Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach.
Lokman SM; Rasheduzzaman M; Salauddin A; Barua R; Tanzina AY; Rumi MH; Hossain MI; Siddiki AMAMZ; Mannan A; Hasan MM
Infect Genet Evol; 2020 Oct; 84():104389. PubMed ID: 32502733
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2).
Masood N; Malik SS; Raja MN; Mubarik S; Yu C
Front Cell Infect Microbiol; 2020; 10():499. PubMed ID: 32974224
[TBL] [Abstract][Full Text] [Related]
10. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
[TBL] [Abstract][Full Text] [Related]
11. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
[TBL] [Abstract][Full Text] [Related]
12. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies.
Papageorgiou AC; Mohsin I
Cells; 2020 Oct; 9(11):. PubMed ID: 33105869
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
14. Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
Tai W; Zhang X; He Y; Jiang S; Du L
Antiviral Res; 2020 Jul; 179():104820. PubMed ID: 32405117
[TBL] [Abstract][Full Text] [Related]
15. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I
Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.
Gupta R; Charron J; Stenger CL; Painter J; Steward H; Cook TW; Faber W; Frisch A; Lind E; Bauss J; Li X; Sirpilla O; Soehnlen X; Underwood A; Hinds D; Morris M; Lamb N; Carcillo JA; Bupp C; Uhal BD; Rajasekaran S; Prokop JW
J Biol Chem; 2020 Aug; 295(33):11742-11753. PubMed ID: 32587094
[TBL] [Abstract][Full Text] [Related]
17. Mutations Strengthened SARS-CoV-2 Infectivity.
Chen J; Wang R; Wang M; Wei GW
J Mol Biol; 2020 Sep; 432(19):5212-5226. PubMed ID: 32710986
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans.
Frutos R; Serra-Cobo J; Chen T; Devaux CA
Infect Genet Evol; 2020 Oct; 84():104493. PubMed ID: 32768565
[TBL] [Abstract][Full Text] [Related]
19. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
20. Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization.
Zhao Z; Sokhansanj BA; Malhotra C; Zheng K; Rosen GL
PLoS Comput Biol; 2020 Sep; 16(9):e1008269. PubMed ID: 32941419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
